Comparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo.
Vander Cruyssen
B
B
De Keyser
F
F
Kruithof
E
E
Mielants
H
H
Van den Bosch
F
F
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D015535:Arthritis, Psoriatic / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006305:Health Status Indicators; D006801:Humans; D000069285:Infliximab; D007596:Joints / Q000473:pathology; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab